Banque Pictet & Cie’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-9,473
Closed -$264K 358
2023
Q3
$264K Buy
+9,473
New +$310K ﹤0.01% 405

Other funds holding ARKG

Banque Pictet & Cie's ARKG Position: Q4 2023 in Review

Banque Pictet & Cie sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2023, closing a stake of 9,473 shares — an estimated $264K sold.

Banque Pictet & Cie first reported a position in ARKG in Q3 2023 and held it in 1 quarter. The position peaked at $264K in Q3 2023. 298 funds tracked by Wall St. Rank hold ARKG as of Q4 2023.

  • Banque Pictet & Cie reported no remaining ARK Genomic Revolution ETF position as of Q4 2023 after selling out during the quarter.
  • Banque Pictet & Cie sold 9,473 ARK Genomic Revolution ETF shares in Q4 2023, an estimated $264K.
  • Banque Pictet & Cie first reported a position in ARK Genomic Revolution ETF in Q3 2023 and held it in 1 quarter.
  • Banque Pictet & Cie's ARK Genomic Revolution ETF position peaked at $264K in Q3 2023.
  • 298 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2023.

Based on Banque Pictet & Cie's 13F filing for Q4 2023, filed 9 Feb 2024.